Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana (DHAPPQ/MIP)
This study is currently recruiting participants.
Verified April 2012 by Kwame Nkrumah University of Science and Technology
Study NCT01231113   Information provided by Kwame Nkrumah University of Science and Technology

First Received on October 29, 2010.   Last Updated on April 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Malaria
Pregnancy Complications
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
artesunate-amodiaquine
Dihydroartemisinin-piperaquine
Additional drug interventions recognized in this trial
Amodiaquine
Artemisinins
Artesunate
Dihydroquinghaosu
Piperaquine
More general drug interventions related to this trial
Amebicides
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Kwame Nkrumah University of Science and Technology


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services